Evidence map›Paper›PMID 29658277›Full record

ArticleBiochemistry2018

Cavitation Enhancement Increases the Efficiency and Consistency of Chromatin Fragmentation from Fixed Cells for Downstream Quantitative Applications.

Anna M Chiarella, Austin L Quimby, Marjan Mehrab-Mohseni, Brian Velasco, Sandeep K Kasoji, Ian J Davis, Paul A Dayton, Nathaniel A Hathaway, Samantha G Pattenden

Open access · bronzeAbstract read
In one paragraph

Article in Biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Anna M ChiarellaDivision of Chemical Biology and Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery, Eshelman School of Pharmacy , The University of North Carolina , Chapel Hill , North Carolina 27599 , United States.
Austin L QuimbyDivision of Chemical Biology and Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery, Eshelman School of Pharmacy , The University of North Carolina , Chapel Hill , North Carolina 27599 , United States.
Marjan Mehrab-MohseniDivision of Chemical Biology and Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery, Eshelman School of Pharmacy , The University of North Carolina , Chapel Hill , North Carolina 27599 , United States.
Brian VelascoJoint Department of Biomedical Engineering , The University of North Carolina and North Carolina State University , Chapel Hill , North Carolina 27599 , United States.
Sandeep K KasojiJoint Department of Biomedical Engineering , The University of North Carolina and North Carolina State University , Chapel Hill , North Carolina 27599 , United States.
Ian J DavisLineberger Comprehensive Cancer Center , The University of North Carolina , Chapel Hill , North Carolina 27599 , United States.
Paul A DaytonLineberger Comprehensive Cancer Center , The University of North Carolina , Chapel Hill , North Carolina 27599 , United States.
Nathaniel A HathawayDivision of Chemical Biology and Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery, Eshelman School of Pharmacy , The University of North Carolina , Chapel Hill , North Carolina 27599 , United States.
Samantha G PattendenDivision of Chemical Biology and Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery, Eshelman School of Pharmacy , The University of North Carolina , Chapel Hill , North Carolina 27599 , United States.ORCID 0000-0003-2057-4629
University of North Carolina at Chapel Hill · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
NRSA IN GENETICST32GM007092 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SEKELSKY, JEFF J. · 1985 to 2019
$5.9M
MECHANISM OF HP1-MEDIATED HETEROCHROMATIN ASSEMBLY AND DURABILITY IN LIVE CELLSR01GM118653 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HATHAWAY, NATHANIEL A. · 2017 to 2021
$1.7M
The application of Enhanced Cavitation to enable DNA and Chromatin Extraction from Archived TissuesR33CA206939 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVIS, IAN J, DAYTON, PAUL A · 2017 to 2019
$1.1M
NCI NIH HHS P30 CA016086NCI NIH HHS R33 CA206939NIGMS NIH HHS R01 GM118653NIGMS NIH HHS T32 GM007092
6 · The paper itself

Abstract

One of the most sensitive, time-consuming, and variable steps of chromatin immunoprecipitation (ChIP) is chromatin sonication. Traditionally, this process can take hours to properly sonicate enough chromatin for multiple ChIP assays. Further, the length of sheared DNA is often inconsistent. In order to faithfully measure chemical and structural changes at the chromatin level, sonication needs to be reliable. Thus, chromatin fragmentation by sonication represents a significant bottleneck to downstream quantitative analysis. To improve the consistency and efficiency of chromatin sonication, we developed and tested a cavitation enhancing reagent based on sonically active nanodroplets. Here, we show that nanodroplets increase sonication efficiency by 16-fold and provide more consistent levels of chromatin fragmentation. Using the previously characterized chromatin in vivo assay (CiA) platform, we generated two distinct chromatin states in order to test nanodroplet-assisted sonication sensitivity in measuring post-translational chromatin marks. By comparing euchromatin to chemically induced heterochromatin at the same CiA:Oct4 locus, we quantitatively measure the capability of our new sonication technique to resolve differences in chromatin structure. We confirm that nanodroplet-assisted sonication results are indistinguishable from those of samples processed with traditional sonication in downstream applications. While the processing time for each sample was reduced from 38.4 to 2.3 min, DNA fragment distribution sizes were significantly more consistent with a coefficient of variation 2.7 times lower for samples sonicated in the presence of nanodroplets. In conclusion, sonication utilizing the nanodroplet cavitation enhancement reagent drastically reduces the amount of processing time and provides consistently fragmented chromatin of high quality for downstream applications.

Indexed as

AnimalsCell Cycle ProteinsChromatinChromatin ImmunoprecipitationDNADNA FragmentationEuchromatinHeterochromatinMiceNanoparticlesOctamer Transcription Factor-3SonicationCell Cycle ProteinsChromatinDNAEuchromatinHeterochromatinOctamer Transcription Factor-3Pou5f1 protein, mouse

Identifiers

PMID29658277
PMCPMC5962036
OpenAlexW2799411227

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.